Pedro Sanchez-Lara

Dr. Pedro Sanchez-Lara

orcid

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 June 2021 in American Journal of Medical Genetics Part A
Verified
Journal Article
Closed access
PDF file
FPFilomena Pirozzi
Filomena Pirozzi
BLBenson Lee
Benson Lee
NHNicole Horsley
Nicole Horsley
DBDeepika D. Burkardt
Deepika D. Burkardt
WDWilliam B. Dobyns
William B. Dobyns
GMGhayda Mirzaa
Ghayda Mirzaa

19 May 2021 in American Journal of Medical Genetics Part A
Verified
Journal Article
Closed access
PDF file
EWErik M. Wolfswinkel
Erik M. Wolfswinkel
PSPedro Sanchez-Lara
Pedro Sanchez-Lara
LJLaya Jacob
Laya Jacob
MUMark M. Urata
Mark M. Urata

25 March 2022 in Genes
Verified
Journal Article
Open access
PDF file
CSChristine F. Stafford
Christine F. Stafford
PSPedro Sanchez-Lara
Pedro Sanchez-Lara
Research has shown that genetics play a key role in the development of autism spectrum disorder (ASD). ASD has been linked to many genes and is a prominent feature in numerous genetic disorders. A genetic evaluation should be offered to any patient who receives a diagnosis of ASD, including deep phenotyping and genetic testing when clinically indicated. When insurance does not cover genetic testing for ASD patients, the lack of medical utility is often cited as a reason for prior authorization request denial. However, ample evidence exists that genetic testing has the power to change clinical management in many of these patients. Genetic testing that results in a diagnosis guides clinicians to screen for associated medical conditions and can direct targeted medical interventions. Given the potential for clinically actionable results, it is important that genetic testing be available and accessible to all patients with ASD.

20 September 2024 in Annals of Neurology
Verified
Journal Article
Closed access
PBPatrick Blackburn
Patrick Blackburn
FEFrédéric Ebstein
Frédéric Ebstein
THTzung-Chien Hsieh
Tzung-Chien Hsieh
MMMarialetizia Motta
Marialetizia Motta
FRFrancesca Clementina Radio
Francesca Clementina Radio
TWTianyun Wang
Tianyun Wang

8 November 2022 in Human Molecular Genetics
Verified
Journal Article
Open access
PDF file
MIMorié Ishida
Morié Ishida
MOMARIA GABRIELA OTERO
MARIA GABRIELA OTERO
CFChristina Freeman
Christina Freeman
PSPedro Sanchez-Lara
Pedro Sanchez-Lara
CGCarlos Guardia
Carlos Guardia
JBJuan S Bonifacino
Juan S Bonifacino
ADP-ribosylation factor 1 (ARF1) is a small GTPase that regulates membrane traffic at the Golgi apparatus and endosomes through recruitment of several coat proteins and lipid-modifying enzymes. Here, we report a pediatric patient with an ARF1-related disorder because of a monoallelic de novo missense variant (c.296 G > A; p.R99H) in the ARF1 gene, associated with developmental delay, hypotonia, intellectual disability and motor stereotypies. Neuroimaging revealed a hypoplastic corpus callosum and subcortical white matter abnormalities. Notably, this patient did not exhibit periventricular heterotopias previously observed in other patients with ARF1 variants (including p.R99H). Functional analysis of the R99H-ARF1 variant protein revealed that it was expressed at normal levels and properly localized to the Golgi apparatus; however, the expression of this variant caused swelling of the Golgi apparatus, increased the recruitment of coat proteins such as coat protein complex I, adaptor protein complex 1 and GGA3 and altered the morphology of recycling endosomes. In addition, we observed that the expression of R99H-ARF1 prevented dispersal of the Golgi apparatus by the ARF1-inhibitor brefeldin A. Finally, protein interaction analyses showed that R99H-ARF1 bound more tightly to the ARF1-effector GGA3 relative to wild-type ARF1. These properties were similar to those of the well-characterized constitutively active Q71L-ARF1 mutant, indicating that the pathogenetic mechanism of the R99H-ARF1 variant involves constitutive activation with resultant Golgi and endosomal alterations. The absence of periventricular nodular heterotopias in this R99H-ARF1 subject also indicates that this finding may not be a consistent phenotypic expression of all ARF1-related disorders.

30 March 2021 in American Journal of Medical Genetics Part A
Verified
Journal Article
Closed access
PDF file
CHClara C. Hildebrandt
Clara C. Hildebrandt
NPNisha Patel
Nisha Patel
JGJohn M. Graham
John M. Graham
MBMichael Bamshad
Michael Bamshad
DNDeborah A. Nickerson
Deborah A. Nickerson
ALAngela E. Lin
Angela E. Lin